{"id":61469,"date":"2024-02-28T07:42:23","date_gmt":"2024-02-28T07:42:23","guid":{"rendered":"https:\/\/medsname.com\/rivamer-2\/"},"modified":"2026-05-01T10:49:16","modified_gmt":"2026-05-01T10:49:16","slug":"rivamer-2","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/rivamer-2\/","title":{"rendered":"Rivamer"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Rivamer?<\/h3>\n<p style=\"margin:0;\"><strong>Rivamer<\/strong> este o capsul\u0103 oral\u0103 de la Sun Pharma care con\u021bine <strong>rivastigmin\u0103 1.5 mg<\/strong> \u2014 un inhibitor dual <strong>acetilcolinesteraz\u0103 + butirilcolinesteraz\u0103<\/strong> utilizat pentru tratamentul simptomatic al <strong>boal\u0103 Alzheimer u\u0219oar\u0103 p\u00e2n\u0103 la moderat\u0103<\/strong> \u0218I <strong>Demen\u021ba \u00een boala Parkinson<\/strong> (singurul inhibitor AChE autorizat pentru PDD). Titrare progresiv\u0103: <strong>1,5 mg de dou\u0103 ori pe zi timp de 2 s\u0103pt\u0103m\u00e2ni \u2192 3 mg de dou\u0103 ori pe zi timp de 2 s\u0103pt\u0103m\u00e2ni \u2192 4,5 mg de dou\u0103 ori pe zi timp de 2 s\u0103pt\u0103m\u00e2ni \u2192 6 mg de dou\u0103 ori pe zi ca doz\u0103 de \u00eentre\u021binere<\/strong>. <strong>Administra\u021bi \u00eentotdeauna \u00eenso\u021bit de m\u00e2ncare.<\/strong> Plasturele transdermic (nedisponibil \u00een stoc) reduce semnificativ efectele secundare gastrointestinale \u0219i este preferat pentru pacien\u021bii care nu tolereaz\u0103 forma oral\u0103.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Rivamer?<\/h2>\n<p>Rivamer este o capsul\u0103 oral\u0103 de la Sun Pharma ce con\u021bine <strong>rivastigmin\u0103 tartrat 1,5 mg<\/strong>. Rivastigmina este un <strong>inhibitor dual pseudo-ireversibil al colinesterazei<\/strong> \u2014 inhib\u0103 ambele <strong>acetilcolinesteraza (AChE)<\/strong> \u0219i <strong>butirilcolinesteraza (BuChE)<\/strong>. Mecanismul dual \u00eel diferen\u021biaz\u0103 de donepezil \u0219i galantamin\u0103, care inhib\u0103 doar AChE.<\/p>\n<p>Rivamer de la Sun Pharma este o capsul\u0103 de 1,5 mg de rivastigmin\u0103 \u2014 doza ini\u021bial\u0103 pentru titrarea de 6\u20138 s\u0103pt\u0103m\u00e2ni \u00een demen\u021ba u\u0219oar\u0103-p\u00e2n\u0103-la-moderat\u0103 Alzheimer \u0219i Parkinson. Titra\u021bi p\u00e2n\u0103 la doza de \u00eentre\u021binere de 12 mg\/zi. Lua\u021bi \u00eentotdeauna cu m\u00e2ncare pentru a minimiza efectele adverse gastrointestinale caracteristice rivastigminei orale. Rivastigmina este singurul inhibitor de colinesteraz\u0103 cu indica\u021bie aprobat\u0103 pentru <strong>Demen\u021ba \u00een boala Parkinson<\/strong> pe l\u00e2ng\u0103 demen\u021ba u\u0219oar\u0103-p\u00e2n\u0103-la-moderat\u0103 Alzheimer. Inhibarea dual\u0103 ACh + BuChE poate conta mai mult \u00een demen\u021ba Parkinson deoarece activitatea BuChE este relativ p\u0103strat\u0103 \u00een boala Parkinson comparativ cu Alzheimer.<\/p>\n<h2 class=\"wp-block-heading\">Cum Func\u021bioneaz\u0103 Rivamer?<\/h2>\n<p>At\u00e2t boala Alzheimer c\u00e2t \u0219i demen\u021ba Parkinson implic\u0103 pierderea neuronilor colinergici. Rivastigmina cre\u0219te acetilcolina sinaptic\u0103 prin inhibare enzimatic\u0103 dual\u0103:<\/p>\n<ul>\n<li><strong>Inhibarea acetilcolinesterazei (AChE)<\/strong> \u2014 mecanismul colinergic standard comun cu donepezil \u0219i galantamin\u0103. AChE este enzima principal\u0103 de degradare a ACh \u00een creierul s\u0103n\u0103tos.<\/li>\n<li><strong>Inhibarea butirilcolinesterazei (BuChE)<\/strong> \u2014 BuChE devine o enzim\u0103 mai important\u0103 de degradare a ACh pe m\u0103sur\u0103 ce Alzheimer progreseaz\u0103 (compens\u00e2nd pierderea AChE) \u0219i este enzima dominant\u0103 de degradare a ACh \u00een demen\u021ba Parkinson. Inhibarea ambelor enzime poate produce un semnal colinergic mai sus\u021binut \u00een boala avansat\u0103.<\/li>\n<li><strong>Legare pseudo-ireversibil\u0103<\/strong> \u2014 rivastigmina se leag\u0103 de AChE\/BuChE timp de ore \u00een loc de minute, permi\u021b\u00e2nd administrarea de dou\u0103 ori pe zi \u00een ciuda unei semi-viteze plasmatice scurte.<\/li>\n<\/ul>\n<p>Apariere a beneficiului cognitiv: observabil\u0103 la <strong>6\u201312 s\u0103pt\u0103m\u00e2ni<\/strong> la doza de \u00eentre\u021binere de 9\u201312 mg\/zi; v\u00e2rf la 6 luni.<\/p>\n<h2 class=\"wp-block-heading\">Utiliz\u0103ri \u0219i indica\u021bii<\/h2>\n<ul>\n<li><strong>Demen\u021b\u0103 Alzheimer u\u0219oar\u0103 p\u00e2n\u0103 la moderat\u0103<\/strong> \u2014 inhibitor de colinesteraz\u0103 de prim\u0103 linie<\/li>\n<li><strong>Demet\u0103 \u00een boala Parkinson (PDD)<\/strong> \u2014 singurul inhibitor de colinesteraz\u0103 cu aceast\u0103 indica\u021bie aprobat\u0103; beneficii cognitive modeste \u0219i \u00eembun\u0103t\u0103\u021bire a aten\u021biei<\/li>\n<li><strong>Demena\u021b\u0103 cu corpii Lewy<\/strong> \u2014 off-label, adesea cea mai responsiv\u0103 la terapia colinergic\u0103 dintre demen\u021be<\/li>\n<li><strong>Demet\u0103 vascular\u0103 de tip mixt<\/strong> \u2014 beneficiu modest \u00een afara indica\u021biilor<\/li>\n<\/ul>\n<p>Rivamer este <strong>prime\u0219te,<\/strong> indicat pentru: boala Alzheimer sever\u0103 (doar donepezil este autorizat \u00een aceast\u0103 etap\u0103), deficien\u021b\u0103 cognitiv\u0103 u\u0219oar\u0103, demen\u021b\u0103 frontotemporal\u0103 (aggraveaz\u0103 simptomele comportamentale), sau ca stimulator cognitiv la adul\u021bi s\u0103n\u0103to\u0219i.<\/p>\n<h2 class=\"wp-block-heading\">Doza Rivamer \u0219i modul de administrare \u2014 TITRARE \u00ceNCET\u0102<\/h2>\n<p>Rivamer este disponibil sub form\u0103 de <strong>1.5 mg<\/strong> capsule. Titrarea pe 6\u20138 s\u0103pt\u0103m\u00e2ni este obligatorie \u2014 rivastigmina are cel mai agresiv profil gastrointestinal dintre to\u021bi inhibitorii AChE atunci c\u00e2nd este administrat\u0103 oral.<\/p>\n<p><strong>Titrare standard 6\u20138 s\u0103pt\u0103m\u00e2ni:<\/strong><\/p>\n<ul>\n<li><strong>S\u0103pt\u0103m\u00e2nile 1\u20132:<\/strong> 1,5 mg de dou\u0103 ori pe zi (total 3 mg\/zi) cu m\u00e2ncare<\/li>\n<li><strong>S\u0103pt\u0103m\u00e2nile 3\u20134:<\/strong> 3 mg de dou\u0103 ori pe zi (total 6 mg\/zi)<\/li>\n<li><strong>S\u0103pt\u0103m\u00e2nile 5\u20136:<\/strong> 4,5 mg de dou\u0103 ori pe zi (total 9 mg\/zi)<\/li>\n<li><strong>S\u0103pt\u0103m\u00e2nile 7\u20138 \u00een continuare:<\/strong> 6 mg de dou\u0103 ori pe zi (total 12 mg\/zi) \u2014 doza maxim\u0103 de \u00eentre\u021binere<\/li>\n<\/ul>\n<h3 class=\"wp-block-heading\">Cum s\u0103 lua\u021bi corect Rivamer<\/h3>\n<ol>\n<li><strong>Administra\u021bi \u00eentotdeauna \u00eenso\u021bit de m\u00e2ncare.<\/strong> Aceasta este cea mai important\u0103 regul\u0103 pentru tolerabilitate. Lua\u021bi doza de diminea\u021b\u0103 cu micul dejun \u0219i doza de sear\u0103 cu cina.<\/li>\n<li><strong>De dou\u0103 ori pe zi, la interval de 12 ore.<\/strong> Rivastigmina are o perioad\u0103 de \u00eenjum\u0103t\u0103\u021bire scurt\u0103 \u2014 consecven\u021ba conteaz\u0103.<\/li>\n<li><strong>\u00cenghi\u021bi\u021bi \u00eentreaga tablet\u0103 cu ap\u0103.<\/strong> Nu deschide\u021bi capsulele.<\/li>\n<li><strong>Dac\u0103 efectele secundare gastrointestinale sunt intolerabile<\/strong>, reveni\u021bi la doza anterioar\u0103 pentru \u00eenc\u0103 2 s\u0103pt\u0103m\u00e2ni \u00eenainte de a \u00eencerca din nou cre\u0219terea dozei. Plasturele transdermic (nu este disponibil aici, dar este disponibil la nivel mondial) reduce efectele secundare gastrointestinale cu 60\u201370% \u0219i este solu\u021bia standard pentru intoleran\u021ba oral\u0103.<\/li>\n<li><strong>Dac\u0103 tratamentul este \u00eentrerupt pentru mai mult de 3 zile<\/strong>, reporni\u021bi cu 1,5 mg de dou\u0103 ori pe zi \u0219i ajusta\u021bi din nou doza. Omiterea ajust\u0103rii dup\u0103 o pauz\u0103 provoac\u0103 simptome gastrointestinale severe, uneori suficient de grave pentru a necesita internarea \u00een spital din cauza deshidrat\u0103rii.<\/li>\n<li><strong>Supravegherea de c\u0103tre \u00eengrijitor este esen\u021bial\u0103.<\/strong> Pacien\u021bii cu demen\u021b\u0103 Alzheimer sau Parkinson rareori reu\u0219esc s\u0103 respecte \u00een mod fiabil dozarea de dou\u0103 ori pe zi sincronizat\u0103 cu mesele f\u0103r\u0103 sprijin.<\/li>\n<li><strong>Reevaluare dup\u0103 6 luni<\/strong> cu teste cognitive formale (MMSE sau MoCA).<\/li>\n<li><strong>Lua\u021bi \u00een considerare trecerea la plasture transdermal<\/strong> dac\u0103 efectele secundare gastrointestinale persist\u0103 la cea mai mic\u0103 doz\u0103 oral\u0103. Plasturele atinge acelea\u0219i niveluri plasmatice de rivastigmin\u0103 cu varia\u021bii mult mai mici \u00eentre v\u00e2rf \u0219i minim.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Efecte Secundare ale Rivamer<\/h2>\n<p><strong>Frecvente (cea mai mare povar\u0103 gastrointestinal\u0103 dintre to\u021bi inhibitorii AChE oral):<\/strong><\/p>\n<ul>\n<li>Gre\u021buri \u0219i \u0219i v\u0103rs\u0103turi severe (\u00een special \u00een timpul titr\u0103rii)<\/li>\n<li>Diaree<\/li>\n<li>Anorexie \u0219i pierdere \u00een greutate<\/li>\n<li>Ame\u021beli, cefalee<\/li>\n<li>Crampe musculare<\/li>\n<li>Tremor (mai ales la pacien\u021bii cu Parkinson)<\/li>\n<li>Insomnie, vise vii<\/li>\n<li>Bradicardie<\/li>\n<\/ul>\n<p><strong>Mai pu\u021bin frecvente, dar importante:<\/strong><\/p>\n<ul>\n<li>Sincop\u0103 \u0219i c\u0103deri<\/li>\n<li>\u00cenr\u0103ut\u0103\u021birea simptomelor motorii Parkinson (tremor, rigiditate)<\/li>\n<li>Incontinen\u021b\u0103 urinar\u0103<\/li>\n<li>\u00cenr\u0103ut\u0103\u021birea astmului sau BPOC<\/li>\n<li>S\u00e2nger\u0103ri gastrointestinale (\u00een special cu AINS)<\/li>\n<\/ul>\n<p><strong>Rare dar necesita aten\u021bie medical\u0103:<\/strong><\/p>\n<ul>\n<li>Bradicardie sever\u0103 \u0219i bloc cardiac complet<\/li>\n<li>Criz\u0103 epileptic\u0103<\/li>\n<li>V\u0103rs\u0103turi severe care provoac\u0103 rupturi esofagiene<\/li>\n<li>Pancreatit\u0103<\/li>\n<li>Reac\u021bii cutanate severe<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Avertismente \u0219i precau\u021bii<\/h2>\n<ul>\n<li><strong>Efecte secundare gastrointestinale severe:<\/strong> rivastigmina oral\u0103 are cea mai mare povar\u0103 de gre\u021buri\/v\u0103\/v\u0103rs\u0103turi dintre to\u021bi inhibitorii AChE. V\u0103rs\u0103turile severe pot provoca deshidratare, tulbur\u0103ri electrolitice \u0219i fisuri esofagiene. Opri\u021bi \u0219i re-titra\u021bi dup\u0103 o \u00eentrerupere a tratament de 3+ zile.<\/li>\n<li><strong>Cardiovascular:<\/strong> rivastigmina \u00eencetine\u0219te frecven\u021ba cardiac\u0103. Precau\u021bie \u00een sindromul sinusului bolnav bloc AV sincope neexplicate. ECG de baz\u0103 \u00eenainte de \u00eenceperea tratamentului.<\/li>\n<li><strong>Simptome motorii Parkinson:<\/strong> rivastigmina poate agrava tremorul \u0219i rigiditatea la pacien\u021bii cu boala Parkinson. Monitoriza\u021bi \u00eendeaproape; mul\u021bi pacien\u021bi cu Parkinson \u00eel tolereaz\u0103 odat\u0103 ce doza este stabilit\u0103.<\/li>\n<li><strong>Boal\u0103 ulceroas\u0103 peptic\u0103, coprescriere de AINS:<\/strong> risc crescut de hemoragie gastrointestinal\u0103. Prescrie\u021bi un inhibitor de pomp\u0103 de protoni la pacien\u021bii cu risc ridicat.<\/li>\n<li><strong>Astm \u0219i BPOC:<\/strong> precau\u021bie \u00een cazul bolii slab controlate.<\/li>\n<li><strong>Anestezie:<\/strong> informa\u021bi anestezistul despre rivastigmin\u0103. Prelungeste efectul relaxantelor musculare depolarizante.<\/li>\n<li><strong>Greutate corporal\u0103 sub 50 kg:<\/strong> precau\u021bie \u2014 risc crescut de efecte adverse dependente de doz\u0103.<\/li>\n<li><strong>Obstruc\u021bie urinar\u0103 (HBP), antecedente de convulsii:<\/strong> utiliza\u021bi cu precau\u021bie.<\/li>\n<li><strong>Suport pentru \u00eengrijitor:<\/strong> esen\u021bial pentru conformitate, sincronizarea cu mesele \u0219i monitorizarea efectelor adverse.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindica\u021bii \u2014 Cine NU ar trebui s\u0103 ia Rivamer<\/h2>\n<ul>\n<li>Hipersensibilitate cunoscut\u0103 la rivastigmin\u0103, alte derivate de carbamat sau orice excipient al capsulei<\/li>\n<li>Afectare hepatic\u0103 sever\u0103 (Child-Pugh C)<\/li>\n<li>Boal\u0103 ulceroas\u0103 peptic\u0103 activ\u0103 (p\u00e2n\u0103 la vindecare)<\/li>\n<li>Bradicardie simptomatic\u0103 sever\u0103, sindromul sinusului bolnav, bloc AV de gradul doi sau trei (f\u0103r\u0103 stimulator cardiac)<\/li>\n<li>Astm\u0103 sever\u0103 necontrolat\u0103 sau BPOC<\/li>\n<li>Sincop\u0103 recent\u0103 neexplicat\u0103<\/li>\n<li>V\u0103rs\u0103turi severe persistente din orice cauz\u0103<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Combina\u021bi cu<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Efect<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Ce s\u0103 face\u021bi<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Anticolinergice (oxicbutinin\u0103, tolterodin\u0103, amitriptilin\u0103, difenhidramin\u0103, hiosciamin\u0103)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Antagonizeaz\u0103 direct mecanismul rivastigminei<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Evita\u021bi combina\u021bia. Schimba\u021bi medicamentele pentru incontinen\u021b\u0103 cu mirabegron.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Al\u021bi inhibitori AChE (donepezil, galantamin\u0103)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Efecte colinergice compuse, f\u0103r\u0103 beneficii suplimentare<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Utiliza\u021bi un singur inhibitor de colinesteraz\u0103 la un moment dat.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Memantin\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Combina\u021bie standard \u00een Alzheimer moderat \u2014 beneficii cognitive aditive, f\u0103r\u0103 interac\u021biune<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ad\u0103ugare standard. Vezi <a href=\"https:\/\/medsbase.com\/ro\/admenta\/\">Admenta<\/a>.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Beta-blocante, blocante ale canalelor de calciu (verapamil, diltiazem), digoxin\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Risc adi\u021bional de bradicardie \u0219i bloc AV<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitoriza\u021bi frecven\u021ba cardiac\u0103 \u0219i ECG.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Succinilcolin\u0103 \u0219i blocante neuromusculare depolarizante (anestezie)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Paralizie marcat prelungit\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Informa\u021bi anestezistul despre rivastigmin\u0103.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">AINS<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Risc crescut de hemoragie gastrointestinal\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Evita\u021bi dac\u0103 este posibil; co-prescrie\u021bi un inhibitor de pomp\u0103 protonic\u0103.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Agoni\u0219ti beta-adrenergici (inhalatoare pentru astm)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Efect bronhodilatator redus din activarea colinergic\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitoriza\u021bi controlul astmului; titra\u021bi inhalatoarele dup\u0103 necesitate.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Antipsihotice<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Risc crescut de sindrom neuroleptic malign (NMS), agravarea simptomelor motorii \u00een Parkinson<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Utiliza\u021bi doza cea mai mic\u0103 posibil\u0103. Evita\u021bi antipsihoticele tipice \u00een demen\u021ba Parkinson.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Levodopa \u0219i medicamente pentru Parkinson<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Antagonism teoretic (rivastigmina colinergic\u0103, agonistul dopaminic anticolinergic)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Majoritatea pacien\u021bilor tolereaz\u0103 combina\u021bia \u2014 monitoriza\u021bi simptomele motorii Parkinson.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Instruc\u021biuni de Depozitare<\/h2>\n<ul>\n<li>Se p\u0103streaz\u0103 la temperatura camerei, <strong>15\u201325\u00b0C<\/strong>. Proteja\u021bi de lumin\u0103 \u0219i umiditate.<\/li>\n<li>P\u0103stra\u021bi capsulele \u00een blisterul original p\u00e2n\u0103 la utilizare.<\/li>\n<li>Nu depozita\u021bi \u00een baie \u2014 umiditatea reduce durata de via\u021b\u0103.<\/li>\n<li>P\u0103stra\u021bi departe de copii \u0219i de pacien\u021bii care pot s\u0103 nu \u00een\u021beleag\u0103 c\u0103 acestea sunt medicamente.<\/li>\n<li>Returna\u021bi capsulele neutilizate la o farmacie pentru eliminare.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Alternative conexe pe MedsBase<\/h2>\n<p>Alte medicamente pentru Alzheimer \u0219i demen\u021b\u0103 disponibile pe MedsBase:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/aricep\/\"><strong>Aricep (donepezil 5 \/ 10 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/donect\/\"><strong>Donect (donepezil 10 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/donemax\/\"><strong>Donemax (donepezil 10 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/admenta\/\"><strong>Admenta (memantine 5 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/galamer\/\"><strong>Galamer (galantamin\u0103 4 mg)<\/strong><\/a><\/li>\n<\/ul>\n<p>Lectur\u0103 util\u0103: <a href=\"https:\/\/medsbase.com\/ro\/everything-you-need-to-know-about-alzheimers-disease\/\">Tot ce trebuie s\u0103 \u0219tii despre boala Alzheimer<\/a> \u00b7 <a href=\"https:\/\/medsbase.com\/ro\/everything-to-know-about-dementia\/\">Tot ce trebuie s\u0103 \u0219tii despre demen\u021b\u0103<\/a> \u00b7 <a href=\"https:\/\/medsbase.com\/ro\/7-ways-to-protect-your-brain-health-as-you-age\/\">7 moduri de a-\u021bi proteja s\u0103n\u0103tatea creierului odat\u0103 cu \u00eenaintarea \u00een v\u00e2rst\u0103<\/a> \u00b7 <a href=\"https:\/\/medsbase.com\/ro\/best-foods-for-a-healthy-brain-and-improved-memory\/\">Cele mai bune alimente pentru un creier s\u0103n\u0103tos \u0219i o memorie \u00eembun\u0103t\u0103\u021bit\u0103<\/a>.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">De ce Rivamer este singurul inhibitor AChE autorizat pentru demen\u021ba \u00een boala Parkinson?<\/h3>\n<p>Dou\u0103 motive. \u00cen primul r\u00e2nd, rivastigmina inhib\u0103 <strong>at\u00e2t AChE c\u00e2t \u0219i butirilcolinesteraza (BuChE)<\/strong>. Activitatea BuChE este relativ p\u0103strat\u0103 \u00een boala Parkinson dar redus\u0103 \u00een Alzheimer \u2014 astfel inhibarea dubl\u0103 conteaz\u0103 mai mult \u00een demen\u021ba Parkinsonian\u0103. \u00cen al doilea r\u00e2nd, rivastigmina a avut singurul studiu randomizat mare (EXPRESS, 2004) care a demonstrat beneficiul cognitiv specific \u00een demen\u021ba asociat\u0103 bolii Parkinson. Donepezilul \u0219i galantamina arat\u0103 efecte similare \u00een date observa\u021bionale dar lipsesc indica\u021bia regulatorie formal\u0103 pentru demen\u021ba Parkinsonian\u0103.<\/p>\n<h3 class=\"wp-block-heading\">De ce trebuie luat Rivamer cu m\u00e2ncare?<\/h3>\n<p>M\u00e2ncarea reduce semnificativ concentra\u021bia maxim\u0103 de rivastigmin\u0103 \u0219i este cel mai important factor \u00een tolerabilitate. Luat pe stomac gol, rivastigmina oral\u0103 provoac\u0103 grea\u021b\u0103 \u0219i v\u0103rs\u0103turi severe la majoritatea pacien\u021bilor \u2014 uneori suficient de grave pentru a necesita spitalizare. Luat la micul dejun \u0219i cin\u0103, aceea\u0219i doz\u0103 este mult mai bine tolerat\u0103.<\/p>\n<h3 class=\"wp-block-heading\">C\u00e2nd voi vedea rezultate de la Rivamer eu sau membru al familiei mele?<\/h3>\n<p>Beneficiu cognitiv vizibil la <strong>6\u201312 s\u0103pt\u0103m\u00e2ni<\/strong> dup\u0103 atingerea dozei de \u00eentre\u021binere de 9\u201312 mg\/zi; maxim la 6 luni. Ca donepezilul \u0219i galantamina, rivastigmina este terapie simptomatic\u0103 \u2014 stabilizeaz\u0103 func\u021bia pentru o perioad\u0103 tipic de 6\u201318 luni. Re-evalua\u021bi cu teste cognitive formale la 6 luni.<\/p>\n<h3 class=\"wp-block-heading\">Ar trebui s\u0103 trec la plasturele cu rivastigmin\u0103?<\/h3>\n<p>Plasturele transdermic (nu este disponibil aici dar este larg disponibil) atinge acelea\u0219i niveluri plasmatice de rivastigmin\u0103 cu varia\u021bie maxim-minim mult mai mic\u0103, reduc\u00e2nd efectele secundare gastrointestinale cu 60\u201370%. Plasturele este solu\u021bia standard pentru pacien\u021bii care nu tolereaz\u0103 rivastigmina oral\u0103 \u0219i este preferat de la \u00eenceput la pacien\u021bii cu grea\u021b\u0103 sever\u0103 de baz\u0103, v\u0103rs\u0103turi din orice cauz\u0103 sau raport\u0103ri de dificultate de \u00eenghi\u021bire de la \u00eengrijitor. Discuta\u021bi cu medicul prescriitor dac\u0103 efectele secundare orale persist\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Poate fi combinat Rivamer cu memantin\u0103?<\/h3>\n<p>Da \u2014 terapie adi\u021bional\u0103 standard \u00een boala Alzheimer moderat\u0103. Rivastigmina + memantin\u0103 produce beneficiu cognitiv aditiv f\u0103r\u0103 interac\u021biuni semnificative. <a href=\"https:\/\/medsbase.com\/ro\/admenta\/\">Admenta<\/a> este partenerul standard.<\/p>\n<h3 class=\"wp-block-heading\">De ce este titrarea at\u00e2t de lent\u0103?<\/h3>\n<p>Rivastigmina are cel mai agresiv profil de efecte secundare gastrointestinale dintre to\u021bi inhibitorii AChE orali. Titrarea de 6\u20138 s\u0103pt\u0103m\u00e2ni (1,5 mg BD \u2192 3 mg BD \u2192 4,5 mg BD \u2192 6 mg BD) permite tractului gastrointestinal s\u0103 se adapteze la fiecare pas. S\u0103rirea titr\u0103rii provoac\u0103 grea\u021b\u0103, v\u0103rs\u0103turi \u0219i diaree intolerabile, uneori suficient de severe pentru a necesita spitalizare pentru deshidratare.<\/p>\n<h3 class=\"wp-block-heading\">Va \u00eenr\u0103ut\u0103\u021bi Rivamer tremorul meu Parkinsonian?<\/h3>\n<p>Posibil \u2014 rivastigmina poate u\u0219or \u00eenr\u0103ut\u0103\u021bi tremorul \u0219i rigiditatea la unii pacien\u021bi Parkinsonieni prin cre\u0219terea tonusului colinergic. Majoritatea pacien\u021bilor o tolereaz\u0103 odat\u0103 ce doza este stabilit\u0103 \u0219i beneficiul cognitiv dep\u0103\u0219e\u0219te de obicei efectul secundar motor modest. Monitoriza\u021bi simptomele motorii Parkinsoniene \u00een timpul titr\u0103rii \u0219i discuta\u021bi cu neurologul dac\u0103 tremorul se \u00eenr\u0103ut\u0103\u021be\u0219te semnificativ.<\/p>\n<h3 class=\"wp-block-heading\">Pot opri Rivamer dac\u0103 nu ajut\u0103?<\/h3>\n<p>Discuta\u021bi cu medicul prescriptor. Dac\u0103 testele cognitive formale la 6 luni nu arat\u0103 niciun beneficiu, rivastigmina poate fi redus\u0103 treptat \u0219i \u00eentrerupt\u0103. Ca \u0219i celelalte inhibitori AChE, \u00eentreruperea brusc\u0103 poate provoca \u00eenr\u0103ut\u0103\u021birea func\u021biilor cognitive \u2014 reduce\u021bi treptat la doza anterioar\u0103 timp de 2 s\u0103pt\u0103m\u00e2ni \u00eenainte de a opri.<\/p>\n<h3 class=\"wp-block-heading\">Rivamer vs donepezil \u2014 care este potrivit?<\/h3>\n<p>Dac\u0103 pacientul are demen\u021b\u0103 asociat\u0103 bolii Parkinson, rivastigmina este prima alegere (singura op\u021biune aprobat\u0103). Dac\u0103 pacientul are boala Alzheimer \u0219i tolereaz\u0103 bine medicamentele orale, donepezilul este de obicei prima alegere din motive de comoditate \u0219i tolerabilitate (o singur\u0103 administrare zilnic\u0103, profil gastrointestinal mai bun). Rivastigmina este rezonabil\u0103 pentru pacien\u021bii cu Alzheimer care nu au r\u0103spuns la donepezil, \u00een special dac\u0103 plasturele cu rivastigm\u0103 (nedisponibil aici) este accesibil.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/amaryl\/\">Amaryl<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/dilantin\/\">Dilantin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glyxambi-empagliflozin\/\">Glyxambi (Empagliflozin)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/amifru\/\">Amifru<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/cordarone\/\">Cordarone<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 \u00cembun\u0103t\u0103\u021be\u0219te func\u021bia cognitiv\u0103<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te amintirea<br \/>\n\u2705 \u00cencetine\u0219te declinul cognitiv<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te activit\u0103\u021bile zilnice<br \/>\n\u2705 Sprijin\u0103 managementul Alzheimer<\/p>\n<p>Rivamer con\u021bine Rivastigmin\u0103.<\/p>","protected":false},"featured_media":61470,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3772,3141,3223],"product_tag":[5038,5039],"class_list":{"0":"post-61469","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-alzheimers-treatment","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","9":"product_tag-rivamer","10":"product_tag-rivastigmine","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/61469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=61469"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/61470"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=61469"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=61469"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=61469"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=61469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}